To help prevent people from getting the Ebola virus, countries around the world paid to help doctors develop a new vaccine. Now that the vaccine has been made, doctors will need to experiment on a large number of people to find out if it works safely.

What is the greatest limitation that scientists are dealing with as they try to figure out how to experiment with the Ebola vaccine?

time
complexity
money
ethics

A is correct simply due to the fact that the longer time passes without an ebola cure, the more people can be potentially infected with it, resulting in less healthy individuals that may be able to volunteer to test potential ebola vaccines. Scientists need healthy volunteers from affected regions in order for rapid clinical trials to occur.

B is correct because of the nature of epidemics. A combination of technical, social, economic, and geographical obstacles slow the progress and dissemination of ebola vaccine information.

C is correct because finance impacts everything from finding resources used in studying ebola to distributing vaccines to affected areas. Economic imbalances or money shortages negatively impact research.

D is correct due to many social factors (more of a subjective answer). Some people think that vaccine distributors discriminate against certain ethnic groups. Others think the governments/other organizations are not effective enough at managing the situation. Still others feel that the search for a cure is not being approached in the right way. In all, there are multiple ways to oppose different aspects of ebola research.

Ultimately, B is correct because it seems to capture the meaning of A, C, and D together.

arshikhan8123 arshikhan8123 · Answer 2 · 2022-07-14T14:33:45+02:00

B)complexity is the greatest limitation that scientists are dealing with as they try to figure out how to experiment with the Ebola vaccine.

Is there a vaccine for Ebola?

Currently, there aren't any certified vaccines to prevent Ebola virus sickness. However, more than one investigational Ebola vaccine had been tested in numerous clinical trials around the arena. NIAID has supported the development of numerous applicants, which includes the rVSV-ZEBOV vaccine developed by means of Merck.

ERVEBO (Ebola Zaire Vaccine, live also referred to as V920, rVSVΔG-ZEBOV-GP, or rVSV-ZEBOV) is authorized by way of the U.S. meals and Drug Administration (FDA) for the prevention of sickness caused by Zaire ebolavirus in individuals 18 years of age and older as a single dose administration.

Learn more about Ebola here: https://brainly.com/question/836713

#SPJ2